Gentian Denas

4.7k total citations · 1 hit paper
82 papers, 2.8k citations indexed

About

Gentian Denas is a scholar working on Rheumatology, Hematology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Gentian Denas has authored 82 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Rheumatology, 39 papers in Hematology and 33 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Gentian Denas's work include Systemic Lupus Erythematosus Research (46 papers), Platelet Disorders and Treatments (35 papers) and Atrial Fibrillation Management and Outcomes (26 papers). Gentian Denas is often cited by papers focused on Systemic Lupus Erythematosus Research (46 papers), Platelet Disorders and Treatments (35 papers) and Atrial Fibrillation Management and Outcomes (26 papers). Gentian Denas collaborates with scholars based in Italy, United Kingdom and United States. Gentian Denas's co-authors include Vittorio Pengo, Elisa Bison, Amelia Ruffatti, A. Banzato, Sabino Iliceto, S. Padayattil Jose, Sophie Testa, Paolo Gresele, Cristina Legnani and Giacomo Zoppellaro and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Gentian Denas

79 papers receiving 2.7k citations

Hit Papers

Clinical course of high‐risk patients diagnosed with anti... 2009 2026 2014 2020 2009 100 200 300 400

Peers

Gentian Denas
Gentian Denas
Citations per year, relative to Gentian Denas Gentian Denas (= 1×) peers A. Banzato

Countries citing papers authored by Gentian Denas

Since Specialization
Citations

This map shows the geographic impact of Gentian Denas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gentian Denas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gentian Denas more than expected).

Fields of papers citing papers by Gentian Denas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gentian Denas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gentian Denas. The network helps show where Gentian Denas may publish in the future.

Co-authorship network of co-authors of Gentian Denas

This figure shows the co-authorship network connecting the top 25 collaborators of Gentian Denas. A scholar is included among the top collaborators of Gentian Denas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gentian Denas. Gentian Denas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Rui, et al.. (2023). Antiphospholipid antibodies in chronic thromboembolic pulmonary hypertension. European Journal of Internal Medicine. 111. 1–4. 4 indexed citations
2.
Pontara, Elena, Elisa Bison, Maria Grazia Cattini, et al.. (2023). Close link between antiphosphatidylserine/prothrombin antibodies, lupus anticoagulant, and activated protein C resistance in tetra antiphospholipid antibody–positive subjects. Journal of Thrombosis and Haemostasis. 21(11). 3138–3144. 4 indexed citations
3.
Pengo, Vittorio, Alessia Bracco, Gentian Denas, & Sabino Iliceto. (2023). Coronary Thrombosis with Distal Embolization in a Young Patient after Orthopaedic Surgery: An Informative Case Report. Seminars in Thrombosis and Hemostasis. 50(6). 894–896. 1 indexed citations
4.
Denas, Gentian, Giacomo Zoppellaro, Serena Granziera, et al.. (2023). Very Elderly Patients With Atrial Fibrillation Treated With Edoxaban. JACC Advances. 2(7). 100569–100569. 2 indexed citations
5.
Zhu, Rui, Chun‐Yan Cheng, Yan Yang, Gentian Denas, & Vittorio Pengo. (2022). Prevalence of aPhosphatidylserine/prothrombin antibodies and association with antiphospholipid antibody profiles in patients with antiphospholipid syndrome: A systematic review and meta-analysis. Thrombosis Research. 214. 106–114. 27 indexed citations
6.
Cattini, Maria Grazia, Elisa Bison, Elena Pontara, et al.. (2020). Tetra positive thrombotic antiphospholipid syndrome: Major contribution of anti‐phosphatidyl‐serine/prothrombin antibodies to lupus anticoagulant activity. Journal of Thrombosis and Haemostasis. 18(5). 1124–1132. 48 indexed citations
7.
Pengo, Vittorio, Ariela Hoxha, Laura Andréoli, et al.. (2020). Trial of Rivaroxaban in AntiPhospholipid Syndrome (TRAPS): Two‐year outcomes after the study closure. Journal of Thrombosis and Haemostasis. 19(2). 531–535. 50 indexed citations
8.
Colli, Andrea, Laura Besola, Eleonora Bizzotto, et al.. (2019). Mechanisms of recurrent regurgitation after transapical off-pump mitral valve repair with neochord implantation†. European Journal of Cardio-Thoracic Surgery. 56(3). 479–487. 14 indexed citations
9.
Cheng, Chun‐Yan, et al.. (2019). Prevalence of antiphospholipid (aPL) antibodies among patients with chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis. Internal and Emergency Medicine. 14(4). 521–527. 22 indexed citations
10.
Jose, S. Padayattil, A. Banzato, Paolo Carraro, et al.. (2018). Point of Care Testing (POCT) to assess drug concentration in patients treated with non-vitamin K antagonist oral anticoagulants (NOACs). Thrombosis Research. 163. 100–104. 9 indexed citations
11.
Zoppellaro, Giacomo, Gentian Denas, Nicola Gennaro, et al.. (2018). Different safety profiles of oral anticoagulants in very elderly non-valvular atrial fibrillation patients. A retrospective propensity score matched cohort study. International Journal of Cardiology. 265. 103–107. 19 indexed citations
12.
Pontara, Elena, A. Banzato, Elisa Bison, et al.. (2018). Thrombocytopenia in high‐risk patients with antiphospholipid syndrome. Journal of Thrombosis and Haemostasis. 16(3). 529–532. 35 indexed citations
13.
Pengo, Vittorio, A. Banzato, Elisa Bison, et al.. (2016). Laboratory testing for antiphospholipid syndrome. International Journal of Laboratory Hematology. 38(S1). 27–31. 22 indexed citations
14.
Pengo, Vittorio, Elisa Bison, Giacomo Zoppellaro, et al.. (2016). APS - Diagnostics and challenges for the future. Autoimmunity Reviews. 15(11). 1031–1033. 23 indexed citations
15.
Pengo, Vittorio, Carlo‐Federico Zambon, Paola Fogar, et al.. (2015). A Randomized Trial of Pharmacogenetic Warfarin Dosing in Naïve Patients with Non-Valvular Atrial Fibrillation. PLoS ONE. 10(12). e0145318–e0145318. 25 indexed citations
16.
Pengo, Vittorio, Amelia Ruffatti, T. Del Ross, et al.. (2013). Confirmation of initial antiphospholipid antibody positivity depends on the antiphospholipid antibody profile. Journal of Thrombosis and Haemostasis. 11(8). 1527–1531. 80 indexed citations
17.
Denas, Gentian, Seena Padayattil Jose, Paolo Gresele, et al.. (2012). Major bleeding in patients undergoing PCI and triple or dual antithrombotic therapy: a parallel-cohort study. Journal of Thrombosis and Thrombolysis. 35(2). 178–184. 10 indexed citations
18.
Banzato, A., Nicola Pozzi, Roberta Frasson, et al.. (2011). Antibodies to Domain I of β2Glycoprotein I are in close relation to patients risk categories in Antiphospholipid Syndrome (APS). Thrombosis Research. 128(6). 583–586. 62 indexed citations
19.
Pengo, Vittorio, Umberto Cucchini, Gentian Denas, et al.. (2009). Standardized Low–Molecular-Weight Heparin Bridging Regimen in Outpatients on Oral Anticoagulants Undergoing Invasive Procedure or Surgery. Circulation. 119(22). 2920–2927. 97 indexed citations
20.
Denas, Gentian, Umberto Cucchini, Roberta Russo, et al.. (2008). Effectiveness and safety of a management protocol to correct over-anticoagulation with oral vitamin K: a retrospective study of 1,043 cases. Journal of Thrombosis and Thrombolysis. 27(3). 340–347. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026